Stockreport

Principia Presents Consistent Positive Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial

PRINCIPIA BIOPHARMA INC COMMON  (PRNB) 
Last principia biopharma inc common earnings: 11/5 04:01 pm Check Earnings Report
PDF ORLANDO, Fla., Dec. 07, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing novel therapies [Read more]